Using Marijuana to Treat Glaucoma

Now with recreational marijuana legalized in Michigan, it’s easier for glaucoma patients to substitute traditional treatment methods for a joint. But does it hurt more than it helps? A University of Michigan expert weighs in.

11:23 AM

Author | Jordyn Imhoff

Eye chart with marijuna

Marijuana increased in popularity in the mid-1970s when there was interest in cannabinoids for reduction in intraocular pressure (IOP), which is the fluid pressure inside the eye. Now, its usage has increased due to its pleasure-inducing side effects, and behind tobacco, alcohol and caffeine, it is the most widely used drug in society, according to Michigan Medicine ophthalmologist, Theresa M. Cooney, M.D.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily updates on iTunes, Google Play and Stitcher

Michigan voters took to the polls in November 2008 and voted in favor of the Michigan Medical Marijuana Act (MMA), which protects people with specific medical conditions from penalties under state law who use marijuana for medical purposes. More recently, recreational marijuana has also been legalized in Michigan.

As of 2019, 23 states, including Michigan, have legalized medical marijuana and some people are substituting their glaucoma medication with the drug. But does marijuana help? Cooney says the answer is complicated.

Glaucoma, the second leading cause of blindness in the United States (first for African Americans in the United States), causes optic neuropathy, a progressive loss of visual field and can lead to permanent, irreversible vision loss if not diagnosed and treated appropriately.

A debilitating condition

The MMA allows the usage of prescribed marijuana for "treating or alleviating pain, nausea, and other symptoms associated with a variety of debilitating medical conditions", which is defined as producing one or more of the following:

Not all cases of glaucoma produce symptoms that classify it as a "debilitating medical condition" like closed-angle glaucoma, according to Cooney. The three types of glaucoma are:

  • Open-angle (chronic) glaucoma

  • Closed-angle (acute) glaucoma

  • Secondary glaucoma

Open-angle glaucoma is a chronic medical condition that is generally painless and although vision threatening, it is a slow or non-progressive disease for which medical and surgical treatments are available. Glaucoma eye drops, registered by the Food and Drug Administration (FDA), have long-term, proven efficacy if taken as prescribed.  

Closed-angle glaucoma is an acute medical condition with sudden onset, that typically lasts only hours to a few days. It can cause pain and/or nausea because of elevated intraocular pressures. However, once effective pharmaceutical treatment is in place, there are no longer symptoms that would be consistent with a debilitating medical condition, as defined by the MMA.

Secondary glaucoma occurs when an identifiable source causes increased eye pressure that results in optic nerve damage and vision loss. This can be closed-angle or open-angle glaucoma.  

Marijuana vs. traditional treatment

There are several classes of drugs proven to be effective as medical treatments for glaucoma. Recent glaucoma drops have also shown effectiveness for up to eight hours.

You'd need to smoke eight to 10 marijuana cigarettes a day for them to have the same effectiveness as regular, glaucoma drops.
Theresa M. Cooney, M.D.

Aside from medications, there exist various surgery options for patients, such as the Xen gel stent, when a tiny tube is implanted in the eye to preserve vision, and the trabeculectomy, when a piece of tissue is removed from eye to create an opening to drain fluid.

Combining medication and marijuana is not recommended, says Cooney, because "we don't know how marijuana interacts with traditional treatment methods since there aren't studies investigating that yet."

She adds that side effects of these traditional medical therapies are generally known to be considerably more mild than those associated with high-dose marijuana usage.

The effects of marijuana are also variable, since not all marijuana is created equal and it is not FDA approved, which is a serious health concern.

"Marijuana can be laced with anything," says Cooney. "There are variable potencies of preparation and more than 400 different chemicals involved."

Marijuana is a Schedule I controlled substance under federal law, meaning that there is a high potential for abuse and there is a lack of accepted safety for its use under medical supervision. It is discouraged from being used in place of any traditional, and studied, treatment options.

The good and the bad

According to Cooney, marijuana can create a 25 percent IOP reduction in 60 to 65 percent of people with or without glaucoma. What exactly causes this within the drug is unknown.

The problem is that IOP reduction lasts from 3 to 3.5 hours. To treat glaucoma effectively, IOP must be controlled around the clock, which likely leads to compliance issues.

"You'd need to smoke eight to 10 marijuana cigarettes a day for them to have the same effectiveness as regular, glaucoma drops," says Cooney. "That's 2,920 to 3,650 a year."

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Aside from the high, marijuana can substantially reduce blood pressure, which is a systemic problem. Reducing blood flow to the optic nerve means increasing susceptibility to optic nerve damage, which worsens glaucoma.

Decreased blood pressure is present within an hour, but in some who experience postural hypotension with hypertension, it can be as quick as 10 to 15 minutes.

Another systemic problem: smoking marijuana cigarettes can cause cardiac palpitations within two to three minutes, which will only return to normal after 90 to 120 minutes.

More apparent than physical alterations are the psychotropic effects that can cause euphoria, dysphoria and disruption of short term memory. These effects prevent individuals from safely driving, operating heavy machinery or functioning at maximum mental capacity. 

Because marijuana is not filtered, neither are the cigarettes. Long-term usage can cause emphysema-like respiratory changes because of their release of tar, carcinogens and other volatile materials.

"There's a higher concentration of these carcinogens in marijuana than tobacco, which increases your cancer risk" says Cooney.

Other long-term side effects include:

  • Hormonal changes, which can increase the risk of poor pregnancy outcomes

  • Difficulty concentrating

  • Impaired immune system responses

  • Impaired motor coordination

  • Addiction, and withdrawal after cessation of smoking

Ocular side effects include:

  • Redness

  • Decreased tear production

  • Double vision

  • Being able to maintain a clear image and focus on distant objects

  • Light sensitivity

  • Eye twitching or spasms of the muscles

Tetrahydrocannabinol (THC)

Studies in the last decade have found receptors for active ingredients of marijuana in the tissues of the eyes. According to Cooney, there has also been research suggesting that local administration of the active ingredients of marijuana may have several neuroprotective effects.

"There have been no long-term studies demonstrating whether or not long-standing usage of marijuana maintains visual function, visual fields or stable optic nerves," says Cooney.

However, there is a question of whether there is potential for THC, a chemical found in marijuana that is not toxic to the lungs, to be beneficial in the treatment of glaucoma.

A concern, Cooney states, is that there is absorption variability from the gastrointestinal tract, meaning there is poor predictability of both its timing and intensity of peak effects.

It has not yet been possible to formulate a THC eye drop that is capable of introducing a sufficient concentration of the drug into the eye due to its low water solubility of active ingredients. Topical applications have been associated with irritation and corneal damage.

"Based on reviews by the National Eye Institute and the Institute of Medicine and on available scientific evidence, the Task Force on Complementary Therapies believes that no scientific evidence has demonstrated increased benefits and/or diminished the risks of marijuana usage to treat glaucoma compared with the wide variety of pharmaceutical agents now available," says Cooney. "But there's still much more to explore with the help of future studies."


More Articles About: Health Management Basic Science and Laboratory Research Addiction and Substance Abuse Alternative Medicine Glaucoma Kellogg Eye Center All Research Topics Eye Care & Vision
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories purple cells floating up close
Health Lab
Study links gene network and pancreatic beta cell defects to type 2 diabetes
Teams from Vanderbilt University Medical Center and the University of Michigan design a comprehensive study that integrates multiple analytic approaches that has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to type 2 diabetes.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Vision Impairment as a Risk Factor for Dementia
The population of older adults living with dementia is expected to swell to nearly 14 million by 2050 and is estimated to cost the US economy more than 500 billion each year. In the absence of a cure for Alzheimer's disease, the primary cause of dementia, there's interest in understanding modifiable risk factors. In theory, getting a handle on the modifiable risk factors for dementia, would enable public health efforts to reduce cognitive decline in dementia at the population level. We've come a long way in understanding the risk factors for Alzheimer's disease and other related dementias. However, there's still work to be done. In this episode, we'll speak with Dr. Josh Ehrlich, a researcher at the University of Michigan, who has examined vision impairment as a risk factor for dementia.
smart watch on wrist
Health Lab
Clinical smart watch finds success at identifying atrial fibrillation
A Michigan Medicine research team developed a prescription wristwatch that continuously monitors the wearer’s heart rhythm and uses a unique algorithm to detect atrial fibrillation. The clinical-grade device, called the Verily Study Watch, proved very accurate at identifying atrial fibrillation in participants.
sketched out bacteria in a dish yellow and blue colors of U-M
Health Lab
This gross mixture has big benefits for the study of bacteria
Michigan Medicine researchers have found that growing bacteria on agar mixed with organs is an efficient and effective way to study infectious pathogens.
green blue map of michigan
Health Lab
How does exposure to ‘forever chemicals’ impact your cancer risk
Pearce, professor of epidemiology at the School of Public Health and co-lead of Rogel’s cancer control and population sciences program, reflects on the project and why bringing this study to Michigan is so critical.
supar molecule teal blue yellow red
Health Lab
Immune protein suPAR links viral infection as possible cause of kidney disease
Through a series of experiments in non-human primates, mice and humans, a multi-institutional team led by researchers from Michigan Medicine and Rush University found that the immune protein soluble urokinase plasminogen activator receptor, or suPAR, is an important link between viral infections and proteinuria; the elevation of protein in the urine is known to cause glomerulopathy, a common form of kidney disease.